High density lipoprotein measurement
|
|
0.800 |
GeneticVariation
|
GWASDB |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
High density lipoprotein measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
High density lipoprotein measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Common variants at 30 loci contribute to polygenic dyslipidemia.
|
19060906 |
2009 |
Triglycerides measurement
|
|
0.800 |
GeneticVariation
|
GWASCAT |
Common variants at 30 loci contribute to polygenic dyslipidemia.
|
19060906 |
2009 |
High density lipoprotein measurement
|
|
0.800 |
GeneticVariation
|
GWASDB |
Common variants at 30 loci contribute to polygenic dyslipidemia.
|
19060906 |
2009 |
Triglycerides measurement
|
|
0.800 |
GeneticVariation
|
GWASDB |
Common variants at 30 loci contribute to polygenic dyslipidemia.
|
19060906 |
2009 |
Serum total cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
A genome wide association study identifies common variants associated with lipid levels in the Chinese population.
|
24386095 |
2013 |
Serum HDL cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Discovery and refinement of loci associated with lipid levels.
|
24097068 |
2013 |
Calcification of coronary artery
|
|
0.700 |
GeneticVariation
|
GWASCAT |
Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis.
|
22916037 |
2012 |
Serum albumin measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genome-wide association study identifies multiple loci influencing human serum metabolite levels.
|
22286219 |
2012 |
Serum HDL cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Serum HDL cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanks.
|
21589926 |
2011 |
Coronary heart disease
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
|
21347282 |
2011 |
Pseudocholinesterase Measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits.
|
21943158 |
2011 |
Serum HDL cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Biological, clinical and population relevance of 95 loci for blood lipids.
|
20686565 |
2010 |
Serum HDL cholesterol measurement
|
|
0.700 |
GeneticVariation
|
GWASDB |
Common variants at 30 loci contribute to polygenic dyslipidemia.
|
19060906 |
2009 |
Age related macular degeneration
|
|
0.040 |
GeneticVariation
|
BEFREE |
SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, LIPC rs10468017, rs493258 and LPL rs12678919 genotypes and haplotype evaluation in patients with age-related macular degeneration.
|
30399423 |
2019 |
Age related macular degeneration
|
|
0.040 |
GeneticVariation
|
BEFREE |
Individuals carrying the lipoprotein lipase (LPL) rs12678919 polymorphism (A → G) had no significant change in the risk of developing AMD (OR = 1.01, CI: 0.92-1.10, P = 0.17).
|
26503844 |
2015 |
Age related macular degeneration
|
|
0.040 |
GeneticVariation
|
BEFREE |
Rs10468017 in LIPC, rs12678919 near LPL and rs1883025 in ABCA1 were not found to be associated with advanced AMD (all p > 0.05).
|
24498989 |
2015 |
Age related macular degeneration
|
|
0.040 |
GeneticVariation
|
BEFREE |
After multivariate adjustment for age, sex, educational level, smoking, BMI, lipid-lowering medication use, cardiovascular disease and diabetes, and for all relevant genetic polymorphisms (ApoE2, ApoE4, CFH Y402H, ARMS2 A69S, LIPC rs10468017, LIPC rs493258, LPL rs12678919, ABCA1 rs1883025 and CETP rs3764261), higher HDL was significantly associated with an increased risk of early (OR = 2.45, 95%CI: 1.54-3.90; P = 0.0002) and any AMD (OR = 2.29, 95%CI: 1.46-3.59; P = 0.0003).
|
24608419 |
2014 |
Polypoidal choroidal vasculopathy
|
|
0.020 |
GeneticVariation
|
BEFREE |
We found no association between PCV and LPL rs12678919, LIPC rs10468017 or CETP rs173539.
|
26624898 |
2015 |
Polypoidal choroidal vasculopathy
|
|
0.020 |
GeneticVariation
|
BEFREE |
LIPC rs493258 and LPL rs12678919 did not show significant associations with the development of PCV (P > 0.05).
|
23950155 |
2013 |